Page 49 - Immunization Practices News Today

The United States Food and Drug Administration authorized the emergency use of updated Moderna and Pfizer COVID-19 vaccines on Sept. 11. The updated vaccine aims to more closely target variants that are currently circulating and to provide better protection against serious COVID-19 consequences, like hospitalization and death, according to a press release.

Committee members raised concerns that a more graded recommendation would contribute to inequity

Best practices to train staff and team members to engage patients and to ease the new vaccine offerings into the workflow are also discussed.

(CNN) — The US Centers for Disease Control and Prevention’s independent vaccine advisers voted 13-1 on Tuesday to recommend updated Covid-19 vaccines for all Americans 6 months of age<a class="excerpt-read-more" href="https://whdh.com/news/cdc-advisers-recommend-updated-covid-19-vaccines/">Read More</a>

The CDC still needs to sign off on shots for everyone 6 months and up. Heres what to know about the new vaccines, when you can get one and how much theyll cost.

Today the U.S. Centers for Disease Control and Preventions Advisory Committee on Immunization Practices voted in favor of a universal recommendation for the use of 2023-2024 COVID-19...

New vaccines will be available by the end of week.

The Food and Drug Administration on Monday approved updated Covid vaccines from Pfizer and Moderna. The U.S. Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices approved the vaccines on Tuesday. The newly approved vaccine is for individuals 12 years and older and granted emergency use authorization for individuals 6 months through 11 years of age.

Vaccines are expected to be delivered to pharmacies and providers soon.

INDIANA - The FDA has signed off on updated COVID-19 vaccines that target circulating variants in the U.S. Drug manufacturers Moderna and Pfizer/BioNTech said. Both vaccine manufacturers have said testing shows that their vaccines are effective against EG.5, the currently dominant stra ...